Related Experiment Videos

Delayed vomiting after papavaretum in paediatric outpatient surgery

Canadian Anaesthetists' Society Journal
|November 1, 1986
PubMed

Insights

Papavaretum significantly increases the risk of vomiting in children after outpatient anesthesia and surgery. This study highlights the importance of careful opiate selection in pediatric anesthesia to minimize post-operative nausea and vomiting.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Surgical Outcomes

Background:

  • Postoperative nausea and vomiting (PONV) is a common complication in pediatric patients.
  • Opiate analgesics are frequently used for pain management after pediatric surgery.
  • Minimizing PONV is crucial for patient comfort and recovery after ambulatory surgery.

Purpose of the Study:

  • To evaluate the specific contribution of papavaretum to the incidence of vomiting.
  • To assess the risk of vomiting within 24 hours following pediatric outpatient anesthesia.
  • To inform the use of opiates in pediatric outpatient anesthesia.

Main Methods:

  • A study involving 129 children undergoing circumcision for outpatient anesthesia.
  • All patients received caudal extradural blockade for postoperative analgesia.
  • Comparison of vomiting incidence between children who received papavaretum and those who did not.

Main Results:

  • The incidence of vomiting was significantly higher in children who received papavaretum (56%) compared to those who did not (15%).
  • The difference in vomiting rates was statistically significant (p < 0.0001).
  • Papavaretum was identified as a contributing factor to postoperative vomiting.

Conclusions:

  • Papavaretum is associated with a substantially increased risk of vomiting in pediatric patients post-anesthesia.
  • The findings underscore the need for careful consideration of opiate choice in pediatric outpatient anesthesia.
  • Strategies to mitigate PONV should be prioritized in this patient population.

Related Concept Videos